In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Label Exemptions With "Consistency In Format" May Be Allowed - FDA

This article was originally published in The Rose Sheet

Executive Summary

Exemption requests from the OTC labeling rule may deviate from elements of the final requirements if they are consistent with the general format outlined in the reg, FDA's ODE V Director Robert DeLap, MD/PhD, said at a working group meeting on the issue in Rockville, Md. Sept. 17.

You may also be interested in...



Off-Package Ingredient Labeling Solution For Small Cosmetic-Drugs - CTFA

Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry and Fragrance Association maintained during an agency-industry workshop in Rockville, Md. Sept. 17.

Off-Package Ingredient Labeling Solution For Small Cosmetic-Drugs - CTFA

Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry and Fragrance Association maintained during an agency-industry workshop in Rockville, Md. Sept. 17.

OTC Labeling Exemption Requests For Ophthalmics Denied By FDA

Two requests for exemptions from certain provisions of the OTC labeling final rule are denied by FDA in Aug. 23 letters. Zee Medical and Automatic Liquid Packaging sought relief from the reg's 6-point type size requirement for their respective OTC ophthalmic products.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel